“Do More, Feel Better, Live Longer” – but don’t take Avandia

Today (13 July 2010), Gardiner Harris of the New York Times published the first investigative piece I have seen on Avandia, Diabetes Drug Maker Hid Test data on Risks, Files Indicate.  Avandia (indicated for patients with type 2 diabetes) was once of the biggest-selling drugs in the world with sales at $3.2 billion in 2006 until [...]